Roche Holding (Mexico) Performance
| ROGN Stock | MXN 6,941 67.51 0.98% |
On a scale of 0 to 100, Roche Holding holds a performance score of 17. The company holds a Beta of -0.45, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Roche Holding are expected to decrease at a much lower rate. During the bear market, Roche Holding is likely to outperform the market. Please check Roche Holding's coefficient of variation, jensen alpha, and the relationship between the downside deviation and information ratio , to make a quick decision on whether Roche Holding's historical price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Roche Holding AG are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Roche Holding showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 5.7 B | |
| Total Cashflows From Investing Activities | -6.6 B |
Roche |
Roche Holding Relative Risk vs. Return Landscape
If you would invest 552,326 in Roche Holding AG on December 24, 2024 and sell it today you would earn a total of 141,812 from holding Roche Holding AG or generate 25.68% return on investment over 90 days. Roche Holding AG is generating 0.3964% of daily returns and assumes 1.7542% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Roche, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Roche Holding Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Roche Holding's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Roche Holding AG, and traders can use it to determine the average amount a Roche Holding's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.226
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ROGN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.75 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.4 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.23 actual daily | 17 83% of assets perform better |
Based on monthly moving average Roche Holding is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Roche Holding by adding it to a well-diversified portfolio.
Roche Holding Fundamentals Growth
Roche Stock prices reflect investors' perceptions of the future prospects and financial health of Roche Holding, and Roche Holding fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Roche Stock performance.
| Return On Equity | 0.45 | |||
| Return On Asset | 0.15 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 5.83 T | |||
| Shares Outstanding | 693.89 M | |||
| Price To Earning | 421.29 X | |||
| Price To Book | 9.80 X | |||
| Price To Sales | 79.71 X | |||
| Revenue | 62.8 B | |||
| EBITDA | 22.26 B | |||
| Cash And Equivalents | 9.06 B | |||
| Cash Per Share | 10.61 X | |||
| Total Debt | 16.08 B | |||
| Debt To Equity | 63.10 % | |||
| Book Value Per Share | 35.03 X | |||
| Cash Flow From Operations | 20.98 B | |||
| Earnings Per Share | 360.31 X | |||
| Total Asset | 92.32 B | |||
About Roche Holding Performance
Evaluating Roche Holding's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Roche Holding has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Roche Holding has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Roche Holding AG engages in the diagnostics and prescription pharmaceuticals businesses in Switzerland, Germany, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE HOLDINGS operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 82089 people.Things to note about Roche Holding AG performance evaluation
Checking the ongoing alerts about Roche Holding for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Roche Holding AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company has 16.08 Billion in debt which may indicate that it relies heavily on debt financing |
- Analyzing Roche Holding's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Roche Holding's stock is overvalued or undervalued compared to its peers.
- Examining Roche Holding's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Roche Holding's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Roche Holding's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Roche Holding's stock. These opinions can provide insight into Roche Holding's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Roche Stock Analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.